0 through 5 (Tukey's HSD post hoc tests, p < 0.0001 for both comparisons for BM and CL), and

the patterns of body size (both BM and CL) of all three treatment groups were significantly

different during weeks 6 through 12 (Tukey's HSD post hoc tests, p < 0.0001 for all comparisons

for BM and CL). Within individual weeks, body size of AL turtles was significantly greater than

those of R and R-AL turtles in weeks 1 through 6 (for BM) and in weeks 1 through 7 (for CL),

and body size of all three groups differed significantly in weeks 7 through 12 (for BM) and in

weeks 8 through 12 (for CL) (Fig. 2-2).

 There were significant effects of time and treatment on condition index (CI) as well as a

significant time by treatment interaction during weeks 0 through 5. There was no significant

overall effect of time on CI during weeks 6 through 12, although there was a significant

interaction between time and treatment group (Table 2-3). The pattern of CI in AL turtles was

significantly different from those of R and R-AL turtles during weeks 0 through 5 (Tukey's HSD

post hoc test, p < 0.0001 for both comparisons), and the pattern of CI in R turtles was

significantly different from those of AL and R-AL turtles during weeks 6 through 12 (Tukey's

HSD post hoc test, p < 0.0001 for both comparisons). The difference between AL and R-AL

turtles approached significance (Tukey's HSD post hoc test, p = 0.076). Within individual

weeks, CI of AL turtles was significantly greater than CI of R and R-AL turtles during weeks 1

through 5, and CI of R-AL turtles was intermediate between those of R and AL turtles in week 6.

In weeks 7 through 12, CI of R turtles was significantly lower than CI of R and R-AL turtles, and

CI of R-AL turtles was consistently but not significantly lower than CI of AL turtles (Fig. 2-3).

 Specific growth rates (SGR) for BM and CL also differed among treatment groups for all

weeks of the experiment. Repeated measures ANOVA of SGR revealed significant time and

treatment effects and interactions between time and treatment group during weeks 1 through 5